ArticleOncotarget2026

Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.

Claudia Fumarola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.